✦ LIBER ✦

Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials group

✍ Scribed by Aamdal, S.; Wolff, I.; Kaplan, S.; Paridaens, R.; Kerger, J.; Schachter, J.; Wanders, J.; Franklin, H.R.; Verweij, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxotere in advanced malignant melanoma:

✍ Aamdal, S.; Verweij, J.; Piccart, M.; Bruntsch, U.; Paridaens, R.; Sulkes, A.; K 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Docetaxel (Taxotere) in advanced renal c

✍ Bruntsch, U.; Heinrich, B.; Kaye, S.B.; de Mulder, P.H.M.; van Oosterom, A.; Par 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 534 KB

Docetaxel (TaxotereTM) in advanced gastr

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

Docetaxel (TaxotereR) is active in non-s

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 140 KB

Results of a phase II trial with cystemu

✍ V. Urosevic; Ph. Chollet; A. Adenis; J. Chauvergne; P. Fargeot; H. Roche; P. Ker 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 279 KB

N-(Phosphonacetyl)-l-aspartate (PALA) in

✍ Kleeberg, U.R.; Mulder, J.H.; Rümke, P.; Thomas, D.; Rozencweig, M. 📂 Article 📅 1982 🏛 Elsevier Science ⚖ 420 KB